Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol

Leukemia and Lymphoma

Volumn 49, Issue 4, 2008, Pages 757-762

  Kikuchi, Akira ^a   Mori, Tetsuya ^b   Fujimoto, Jun Ichiro ^c   Kumagai, Masaaki ^b   Sunami, Shosuke ^d   Okimoto, Yuri ^e   Tsuchida, Masahiro ^f  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d NARITA RED CROSS HOSPITAL   (Japan)

^e CHIBA CHILDREN'S HOSPITAL   (Japan)

^f Ibaraki Children's Hospital   (Japan)

Author keywords

B ALL; B NHL; Intensified chemotherapy; TCCSG NHL B9604

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; EPIRUBICIN; ETOPOSIDE; FOLINATE CALCIUM; HYDROCORTISONE; METHOTREXATE; PREDNISOLONE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADVANCED CANCER; B CELL LEUKEMIA; B CELL LYMPHOMA; BRAIN HEMORRHAGE; CANCER LOCALIZATION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SECOND CANCER; SEPSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BURKITT LYMPHOMA; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; HUMANS; INFANT; LYMPHOMA, B-CELL; METHOTREXATE; NEOPLASMS, SECOND PRIMARY; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 42049118129     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701843239     Document Type: Conference Paper

References (15)

1. Jaffe, E. S., Harris, N. L., Stein, H. and Vardiman, J. W. (2001) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer (IARC), Lyon, France
2. Gasparini, M., Lombardi, F., Gianni, M. C., Lattuada, A., Rilke, F. and Fossati-Bellani, F. (1983) Childhood non-Hodgkin's lymphoma: Prognostic relevance of clinical stage and histologic subgroups. Am J Pediatr Hematol Oncol, 5, pp. 161-171.
3. Anderson, J., Jenkin, R. D., Wilson, J. F., Kjerdberg, C. R., Sposto, R. and Chilcote, R. R. (1993) Long-term follow up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Children's Cancer Group. J Clin Oncol, 11, pp. 1024-1032.
4. Bowman, W. P., Shuster, J. J., Cook, B., Griffin, T., Behm, F. and Pullen, J. (1996) Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study. J Clin Oncol, 14, pp. 1252-1261.
5. Brecher, M. L., Schwenn, M. R., Coppes, M. J., Bowmann, W. P., Link, M. P. and Berard, C. W. (1997) Fractionated cyclophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): A randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol, 29, pp. 526-533.
6. Reiter, A., Schrappe, M., Tiemann, M., Ludwig, W. D., Yakisan, E. and Zimmermann, M. (1999) Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of Berlin - Frankfurt - Munster Group Trial BFM 90. Blood, 49, pp. 3294-3306.
7. Atra, A., Imeson, J. D., Hobson, R., Gerrard, M., Hann, I. M. and Eden, O. B. (2000) Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): Results of the United Kingdom Children Cancer Study Group (UKCCSG) B9002 protocol. Br J Cancer, 82, pp. 1396-1402.
8. Patte, C., Auperin, A., Michon, J., Behrendt, H., Leverger, G. and Freppaz, D. (2001) The Societe Francasie d'Oncologie Pediatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 97, pp. 3370-3379.
9. Cairo, M. S., Krailo, M. D., Morse, M., Hutchinson, R. J., Harris, R. E. and Kjerdsberg, C. R. (2002) Long-term follow-up of short intensive multiagent without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: A Children's Cancer Group report. Leukemia, 16, pp. 594-600.
10. Spreafico, F., Massimino, M., Luksch, R., Riccardi, R., Tesoro-Tess, J. D. and Gandola, L. (2002) Intensive very short chemotherapy for advanced Burkitt's lymphoma in children. J Clin Oncol, 20, pp. 2783-2788.
11. Acquatella, G., Insausti, C. L., Garcia, R., Gomez, R., Hernandez, M. and Carneiro, M. (2004) Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Pediatr Blood Cancer, 43, pp. 580-586.
12. Murphy, S. B. (1980) Classification, staging and end results of treatment in childhood non-Hodgkin's lymphoma: Dissimilarities from lymphomas in adults. Semin Oncol, 7, pp. 332-339.
13. Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R. and Sposto, R. (2007) Results of the randomized international trial of LMB-96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: It is possible to reduce treatment for the early responding patients. Blood, 109, pp. 2773-2780.
14. Woessmann, W., Seidemann, K., Mann, G., Zimmermann, M., Burkhardt, B. and Oschlies, I. (2005) The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: A report from the BFM group study NHL-BFM95. Blood, 105, pp. 948-958.
15. Cairo, M. S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, R. and Michon, J. (2007) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood, 109, pp. 2736-2743.